The Russian Biopharmaceuticals and Biomedicine Market

Executive Summary (continued)

Executive Summary

Key Companies to Watch in 2015

Research Scope and Objective

Russian Economy Overview

Healthcare Market Overview

Biopharmaceuticals Market Overview

Biopharmaceuticals Market Overview (continued)

Market Drivers

Drivers—Explained

Market Restraints

Restraints—Explained

Russian Biopharmaceuticals Market—Revenue Forecast

Regulatory Environment

Complex Program for Development of Biotechnology in the Russian Federation Until 2020

Complex Program for Development of Biotechnology in the Russian Federation Until 2020 (continued)

Key Government Support Mechanisms—Overview

Key Government Support Mechanisms—Biotech Clusters

Key Government Support Mechanisms—Biotech Clusters (continued)

Key Government Support Mechanisms—Technology Platforms

Key Government Support Mechanisms—ZHNVLP List and Import Substitution

Biotechnology Investment—State Development Institutions

Biotechnology Investment—Venture Capital

Biopharmaceuticals Market—Percent Revenue Breakdown by Segment

Biopharmaceuticals Segment Overview—Cytokines

Biopharmaceuticals Segment Overview—PKI and Coagulants

Biopharmaceuticals Segment Overview—Hormones

Biopharmaceuticals Segment Overview—Monoclonal Antibodies

Vaccines Segment

Vaccines Segment (continued)

Vaccines Segment (continued)

Vaccines Segment (continued)

Vaccines Segment (continued)

Antibiotics and Bacteriophages

Antibiotics and Bacteriophages (continued)

Antibiotics and Bacteriophages (continued)

Biomedicine Market Overview

Biomedicine Market Overview (continued)

Market Drivers

Drivers—Explained

Market Restraints

Restraints—Explained

Cell Technologies, Gene Therapy, and Regenerative Medicine

Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)

Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)

Nanomedicine and Targeted Drug Delivery

Nanomedicine and Targeted Drug Delivery (continued)

Biocompatible and Biodegradable Medical Materials

Biocompatible and Biodegradable Medical Materials (continued)

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future”

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)

Biocompatible and Biodegradable Medical Materials—Projects of TP “Medicine of the Future” (continued)

Diagnostics Systems, Biochips, and Biosensors

Diagnostics Systems, Biochips, and Biosensors (continued)

Diagnostics Systems, Biochips, and Biosensors (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

Three Big Predictions

Legal Disclaimer

Import Substitution of Biopharmaceuticals From the ZHNVLP List

Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)

Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)

List of Acronyms

The Frost & Sullivan Story

Value Proposition

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy